FENC
NASDAQ · Biotechnology
Fennec Pharmaceuticals Inc
$6.17
+0.02 (+0.33%)
Open$6.18
Previous Close$6.15
Day High$6.45
Day Low$6.15
52W High$9.92
52W Low$4.68
Volume—
Avg Volume142.8K
Market Cap249.90M
P/E Ratio—
EPS$-0.25
SectorBiotechnology
Analyst Ratings
Strong Buy
13 analysts
Price Target
+383.0% upside
Current
$6.17
$6.17
Target
$29.80
$29.80
$21.84
$29.80 avg
$37.23
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 57.12M | 74.30M | 77.18M |
| Net Income | -524,734 | -6,101,542 | -7,191,772 |
| Profit Margin | -0.9% | -8.2% | -9.3% |
| EBITDA | 3.09M | -9,610,170 | -10,191,915 |
| Free Cash Flow | — | -4,689,819 | -4,353,916 |
| Rev Growth | — | -7.2% | -5.1% |
| Debt/Equity | 0.32 | 0.51 | 0.45 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $214.87 | -1.20% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $354.05 | +0.63% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $140.73 | +0.98% | 19.6 | 166.66B |
| VRTX | Vertex Pharmaceuticals Inc | $449.71 | +0.71% | 29.1 | 114.87B |
| REGN | Regeneron Pharmaceuticals | $776.21 | +0.46% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $330.03 | -0.25% | 139.7 | 43.84B |